1. Gastrin-releasing peptide links stressor to cancer progression

   • Xinqiu Li
   • Yunfu Lv
   • Zongfang Li

   Review 06 February 2010 Pages: 483 - 491

   

2. Transglutaminase 2 as a cisplatin resistance marker in non-small cell lung cancer

   • Kang-Seo Park
   • Hyun-Kyoung Kim
   • Kyeong-Man Hong

   Original Paper 18 September 2009 Pages: 493 - 502

   

3. Phase II study of capecitabine plus oxaliplatin (XELOX) as first-line treatment and followed by maintenance of capecitabine in patients with metastatic colorectal cancer

   • Yu Hong Li
   • Hui Yan Luo
   • Rui Hua Xu

   Original Paper 24 September 2009 Pages: 503 - 510

   

4. Modified apical dissection of the prostate improves early continence in laparoscopic radical prostatectomy: technique and initial results

   • Xin Gao
   • Ke-Bing Wang
   • Jian-Guang Qiu

   Original Paper 23 September 2009 Pages: 511 - 516

   

5. The clinical significance of ascitic fluid CEA in advanced gastric cancer with ascites

   • Minkyu Jung
   • Hei-Cheul Jeung
   • Sun Young Rha

   Original Paper 23 September 2009 Pages: 517 - 526

   

6. Clinical outcomes of advanced non-small cell lung cancer patients screened for epidermal growth factor receptor gene mutations

   • Kimihide Yoshida
   • Yasushi Yatabe
   • Toyoaki Hida

   Original Paper 24 September 2009 Pages: 527 - 535

   

7. US-guided interstitial chemotherapy using paclitaxel temperature-responsive gel for breast cancer treatment in rat

   • Chen Zhi-kui
   • Lin Li-wu
   • Cai Min-xian

   Original Paper 24 September 2009 Pages: 537 - 545

   

8. The similar survival benefits of stable disease and partial response to pemetrexed in previously treated non-small cell carcinoma patients

   • Hye-Ryoun Kim
   • Min Soo Kang
   • Jae Cheol Lee

   Original Paper 30 September 2009 Pages: 547 - 552

   

9. Expression status of Zic family member 2 as a prognostic marker for oral squamous cell carcinoma

   • Kentaro Sakuma
   • Atsushi Kasamatsu
   • Katsuhiro Uzawa

   Original Paper 27 September 2009 Pages: 553 - 559

   

10. Age as a prognostic factor for patients with osteosarcoma: an analysis of 438 patients

    • Matthew T. Harting
    • Kevin P. Lally
    • Martin L. Blakely

    Original Paper 27 September 2009 Pages: 561 - 570

    

11. Loss of GDF-15 abolishes Sulindac chemoprevention in the Apc^Min/+ mouse model of intestinal cancer

    • Teresa A. Zimmers
    • Juan C. Gutierrez
    • Leonidas G. Koniaris

    Original Paper 27 September 2009 Pages: 571 - 576

    

12. Expression profiling of formalin-fixed paraffin embedded primary human uveal melanomas using DASL matrices

    • Sebastian Di Cesare
    • Andre Nantel
    • Miguel N. Burnier Jr

    Original Paper 13 October 2009 Pages: 577 - 586

    

13. Expression of Nucleostemin, epidermal growth factor and epidermal growth factor receptor in human esophageal squamous cell carcinoma tissues

    • Gongyuan Zhang
    • Qiao Zhang
    • Weidong Wu

    Original Paper 13 October 2009 Pages: 587 - 594

    

14. Genomic aberrations in hepatocellular carcinoma related to osteopontin expression detected by array-CGH

    • Jin-Cai Wu
    • Bing-Sheng Sun
    • Lun-Xiu Qin

    Original Paper 16 October 2009 Pages: 595 - 601

    

15. Inhibitory effect of cucurbitacin E on pancreatic cancer cells growth via STAT3 signaling

    • Chunyan Sun
    • Meixia Zhang
    • Yihui Deng

    Original Paper 09 October 2009 Pages: 603 - 610

    

16. Procalcitonin as a predictive marker of infections in chemoinduced neutropenia

    • Luisa Carnino
    • Silvia Betteto
    • Giulio Mengozzi

    Original Paper 30 October 2009 Pages: 611 - 615

    

17. Long-term follow-up and a detailed prognostic analysis of patients with oropharyngeal cancer treated with radiotherapy

    • Natsuo Tomita
    • Takeshi Kodaira
    • Nobukazu Fuwa

    Original Paper 27 October 2009 Pages: 617 - 623

    

18. Clinical study of recombinant adenovirus-p53 combined with fractionated stereotactic radiotherapy for hepatocellular carcinoma

    • Zhi-xiang Yang
    • Dong Wang
    • Xiao-hui Liu

    Original Paper 31 October 2009 Pages: 625 - 630

    

19. Single-nucleotide polymorphisms in BER and HRR genes, XRCC1 haplotypes and breast cancer risk in Caucasian women

    • Silvia Sterpone
    • Valeria Mastellone
    • Renata Cozzi

    Rapid Communication 06 February 2010 Pages: 631 - 636

    

20. Erratum to: Overexpression of Cks1 is associated with poor survival by inhibiting apoptosis in breast cancer

    • Xiao-Chun Wang
    • Li-Li Tian
    • Ai-min Meng

    Retraction Note 30 January 2010 Pages: 637 - 637